Cosmo Pharmaceuticals N.V. (CMOPF)
OTCMKTS
· Delayed Price · Currency is USD
55.00
-7.80 (-12.42%)
At close: Apr 10, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
|---|---|---|---|---|---|---|
| Own Products | 52.97M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Own Products Growth | -0.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generic Products, Specialty Drugs and Related Services | 14.58M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generic Products, Specialty Drugs and Related Services Growth | 10.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalties | 11.87M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalties Growth | 19.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Licence Fees, Up-front Fees and Milestones | 8.83M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Licence Fees, Up-front Fees and Milestones Growth | -63.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 13.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MMX Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MMX Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Marketed Products - Eleview | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Marketed Products - Eleview Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Related Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Related Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| GI Genius | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
|---|---|---|---|---|---|---|
| Italy | 90.14M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Italy Growth | -12.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|